14.8 %A proportion of males (14.8%) were more likely to show an understanding of the complementary association of HIV and TB than females (10.5%).
Nigeriatuberculose · VIH/sidapublished 2024BMC public healthPubMeddocument of 4 observations
Gold tier: mechanically validated evidence, with its primary source.
1,729 evidence items · page 41 / 70
14.8 %A proportion of males (14.8%) were more likely to show an understanding of the complementary association of HIV and TB than females (10.5%).
Nigeriatuberculose · VIH/sidapublished 2024BMC public healthPubMeddocument of 4 observations
17 %17% of HIV-infected patients regressed ≥1 Metavir stage.
NigeriaVIH/sidapublished 2019The Journal of antimicrobial chemotherapyPubMeddocument of 8 observations
8 %Subtype G accounted for 8% of the 1442 HIV-1 pol sequences analysed.
NigeriaVIH/sidaobserved 1999-2014published 2020Scientific reportsPubMeddocument of 6 observations
35.6 %The proportion of the association between stigma and medication adherence explained through mediation by depression was 35.6%.
Nigeriadépression · VIH/sidaobserved October 2021 to February 2022published 2024Journal of behavioral medicinePubMeddocument of 4 observations
73.05 utility_scoreThe EQ-5D utility score of people living with HIV/AIDS on antiretroviral therapy in a Nigerian tertiary hospital was 73.05 ± 10.36.
NigeriaVIH/sidapublished 2021Value in health regional issuesPubMeddocument of 4 observations
3.38 aORFemale sex workers residing in the South East geopolitical zone of Nigeria had higher odds of prenatal HIV testing compared to those in the South South zone (adjusted odds ratio = 3.38).
NigeriaVIH/sidapublished 2024International journal of STD & AIDSPubMeddocument of 12 observations
62 %In pilot mechanistic subsets, M184V mutation was present in 62% of viraemic participants.
NigeriaVIH/sidaobserved 2019–2021published 2026Frontiers in public healthPubMeddocument of 7 observations
37.7 %37.7% of adolescents reported falling asleep as a reason for missing medications.
NigeriaVIH/sidapublished 2022AIDS carePubMeddocument of 12 observations
4.1 %HIV prevalence in Nigeria reduced from 4.1% in 2010 to 1.4% in 2019.
NigeriaVIH/sidaobserved 2010published 2025AIDS research and therapyPubMeddocument of 4 observations
7.6 %The coinfection rate of herpes simplex virus (HSV)-1 and HSV-2 among patients with HIV in Nigeria was 7.6%.
Nigeriaherpes simplex virus (HSV)-1 · herpes simplex virus (HSV)-2 · VIH/sidaobserved 2019published 2023BMJ openPubMeddocument of 5 observations
14 %Adverse drug reaction accounted for 14.0% (n=30) of the 215 drug therapy problems identified among PLWH in the study.
NigeriaVIH/sidapublished 2021The Pan African medical journalPubMeddocument of 11 observations
1.19 aORIncreasing symptom burden was associated with higher likelihood of retention at 12 months (adjusted odds ratio = 1.19).
NigeriaVIH/sidapublished 2020Journal of the International Association of Providers of AIDS CarePubMeddocument of 6 observations
3.7 %In a prospective observational study conducted from October 2015 to March 2016 at Imo State University Teaching Hospital Orlu, Nigeria, the HIV seroconversion rate among pregnant women who previously tested HIV negative in antenatal clinic was 3.7%.
NigeriaVIH/sidaobserved October 2015 to March 2016published 2019Nigerian journal of clinical practicePubMeddocument of 3 observations
64.2 %Among 352 HIV-positive patients in Nigeria, 64.2% were female.
NigeriaVIH/sidapublished 2021African health sciencesPubMeddocument of 5 observations
86.4 %Participants' level of knowledge of HIV/AIDS was good, at 86.4% for males and 86.3% for females.
NigeriaVIH/sidapublished 2019West African journal of medicinePubMeddocument of 7 observations
1.67 %Malaria RDT result was positive in 1/60 (1.67%) of the HIV-negative group.
Nigeriapaludisme · VIH/sidaobserved 2018–2019published 2024BMC infectious diseasesPubMeddocument of 15 observations
2.8 %Overall HIV prevalence was 2.8% among 15,609 participants in the Akwa Ibom AIDS Indicator Survey.
NigeriaVIH/sidapublished 2020PloS onePubMeddocument of 4 observations
16 %CRF43_02G accounted for 16% of the 1442 HIV-1 pol sequences analysed.
NigeriaVIH/sidaobserved 1999-2014published 2020Scientific reportsPubMeddocument of 6 observations
503 individualsAmong 1266 respondents living with HIV who were taking antiretroviral drugs, 503 (40%) did not disclose their HIV status to interviewers in a nationally representative HIV sero-survey conducted in Nigeria in 2018.
NigeriaVIH/sidaobserved 2018published 2023AIDS (London, England)PubMeddocument of 2 observations
24.9 %The prevalence of hypertension among people living with HIV (PLHIV) receiving care at a Nigerian hospital was 24.9%.
Nigeriahypertension artérielle · VIH/sidapublished 2022The Pan African medical journalPubMeddocument of 2 observations
2.17 odds_ratioAmong HIV-positive individuals, hypertension was associated with increased risk of prevalent chronic kidney disease, with an adjusted odds ratio of 2.17.
Nigeriahypertension artérielle · maladie rénale chronique · VIH/sidapublished 2020American journal of kidney diseases : the official journal of the National Kidney FoundatiPubMeddocument of 7 observations
31.8 %Among 415 people living with HIV attending a tertiary care center in Kano, Nigeria, 31.8% cited elimination of travel expenses as a primary motivation for teleconsultation acceptance.
NigeriaVIH/sidapublished 2025Telemedicine journal and e-health : the official journal of the American Telemedicine AssoPubMeddocument of 6 observations
10 timesYoung men who have sex with men (YMSM) in Nigeria are ten times more likely to be living with HIV-1 than other young men.
NigeriaVIH/sidapublished 2024AIDS and behaviorPubMeddocument of 10 observations
0.2 %LGA-level HIV prevalence in Nigeria ranged from 0.2% to 8.5% based on data from the Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) conducted from July to December 2018.
NigeriaVIH/sidaobserved 2018published 2022PloS onePubMeddocument of 5 observations
45.1 %45.1% of respondents reported being exposed to the youth facilitator-driven interventions.
NigeriaVIH/sidapublished 2023PloS onePubMeddocument of 3 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.